Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F C Ames

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
American Journal of Surgery|February 2, 1999
Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancerH M Kuerer, L A Newman, A U Buzdar, et al.
American Journal of Surgery|September 27, 2000
The correlation of axillary ultrasonography with histologic breast cancer downstaging after induction chemotherapyG Vlastos, B D Fornage, N Q Mirza, et al.
Annals of Surgical Oncology|January 6, 2000
Primary tumor response to induction chemotherapy as a predictor of histological status of axillary nodes in operable breast cancer patientsJ T Lenert, G Vlastos, N Q Mirza, et al.
The Cancer Journal From Scientific American|August 5, 1998
Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node statusH M Kuerer, L A Newman, A U Buzdar, et al.
Annals of Surgical Oncology|July 14, 2000
Prognostic implications of pathological lymph node status after preoperative chemotherapy for operable T3N0M0 breast cancerF Meric, N Q Mirza, A U Buzdar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2000
Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancerT M Breslin, L Cohen, A Sahin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapyH M Kuerer, L A Newman, T L Smith, et al.
Annals of Surgical Oncology|October 18, 2000
Ductal carcinoma-in-situ: long-term results of breast-conserving therapyN Q Mirza, G Vlastos, F Meric, et al.
Journal of the National Cancer Institute|February 3, 2000
Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinomaG N Hortobagyi, A U Buzdar, R L Theriault, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
American Journal of Surgery|February 2, 1999
Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancerH M Kuerer, L A Newman, A U Buzdar, et al.
American Journal of Surgery|September 27, 2000
The correlation of axillary ultrasonography with histologic breast cancer downstaging after induction chemotherapyG Vlastos, B D Fornage, N Q Mirza, et al.
Annals of Surgical Oncology|January 6, 2000
Primary tumor response to induction chemotherapy as a predictor of histological status of axillary nodes in operable breast cancer patientsJ T Lenert, G Vlastos, N Q Mirza, et al.
The Cancer Journal From Scientific American|August 5, 1998
Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node statusH M Kuerer, L A Newman, A U Buzdar, et al.
Annals of Surgical Oncology|July 14, 2000
Prognostic implications of pathological lymph node status after preoperative chemotherapy for operable T3N0M0 breast cancerF Meric, N Q Mirza, A U Buzdar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2000
Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancerT M Breslin, L Cohen, A Sahin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapyH M Kuerer, L A Newman, T L Smith, et al.
Annals of Surgical Oncology|October 18, 2000
Ductal carcinoma-in-situ: long-term results of breast-conserving therapyN Q Mirza, G Vlastos, F Meric, et al.
Journal of the National Cancer Institute|February 3, 2000
Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinomaG N Hortobagyi, A U Buzdar, R L Theriault, et al.
Pageof 8